First evidence for helical transitions in supercoiled DNA by amyloid β peptide (1-42) and aluminum -: A new insight in understanding Alzheimer's disease

被引:67
|
作者
Hegde, ML
Anitha, S
Latha, KS
Mustak, MS
Stein, R
Ravid, R
Rao, KSJ [1 ]
机构
[1] Cent Food Technol Res Inst, Dept Biochem & Nutr, Mysore 570013, Karnataka, India
[2] ITPL, Inst Biotechnol, Ctr Human Genet, Bangalore, Karnataka, India
[3] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Neurobiochem, IL-69978 Ramat Aviv, Israel
[4] Netherlands Brain Bank, Amsterdam, Netherlands
关键词
Alzheimer's disease; pUC18 supercoiled DNA; helical transitions; topoisomer separation; B-DNA; Z-DNA; psi-DNA;
D O I
10.1385/JMN:22:1-2:19
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously, we evidenced a B --> Z helical change in Alzheimer's brain genomic DNA, leading to a hypothesis that Alzheimer's disease (AD) etiological factors such as aluminum (Al), amyloid beta (Abeta) peptide, and Tau might play a role in modulating DNA topology. In the present study, we investigated the interaction of A1 and Abeta with DNA. Our results show that Abeta(1-42) could induce a B --> psi (Psi) conformational change in pUC 18 supercoiled DNA (scDNA), Abeta(1-16) caused an altered B-form, whereas A1 induced a complex B-C-A mixed conformation. Ethidium bromide binding and agarose gel electrophoresis studies revealed that A1 uncoiled the DNA to a fully relaxed form, whereas Abeta(1-42) and Abeta(1-16) effected a partial uncoiling and also showed differential sensitivity toward chloroquine-induced topoisomer separation. Our findings show for the first time that Abeta and A1 modulate both helicity and superhelicity in scDNA. A new hypothetical model explaining the potential toxicity of Abeta and A1 in terms of their DNA binding properties leading to DNA conformational alteration is proposed.
引用
收藏
页码:19 / 31
页数:13
相关论文
共 50 条
  • [1] First evidence for helical transitions in supercoiled DNA by amyloid β peptide (1–42) and aluminumA new insight in understanding Alzheimer’s disease
    Muralidhar L. Hegde
    Suram Anitha
    Kallur S. Latha
    Mohammed S. Mustak
    Reuven Stein
    Rivka Ravid
    K. S. Jagannatha Rao
    Journal of Molecular Neuroscience, 2004, 22 : 19 - 31
  • [2] A new evidence for DNA nicking property of amyloid β-peptide (1-42):: Relevance to Alzheimer's disease
    Suram, A.
    Hegde, M. L.
    Rao, K. S. J.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2007, 463 (02) : 245 - 252
  • [3] A new insight into interaction of amyloid beta peptide and tau with supercoiled DNA: relevance to Alzheimer's disease
    Anitha, S
    Rao, KSJ
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 : 139 - 139
  • [4] Plasma amyloid β-peptide 1-42 and incipient Alzheimer's disease
    Mayeux, R
    Tang, MX
    Jacobs, DM
    Manly, J
    Bell, K
    Merchant, C
    Small, SA
    Stern, Y
    Wisniewski, HM
    Mehta, PD
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 412 - 416
  • [5] Evidence for helical transitions in DNA topology in hippocampus region of brain affected with Alzheimer's disease: A new insight in understanding Alzheimer's disease pathology
    Suram, A
    Muralidhar, H
    Mushtaque, S
    Jagannatha, R
    Kalluri, L
    Viswamitra, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S516 - S516
  • [6] Molecular simulation to aid in the understanding of the Aβ(1-42) peptide of Alzheimer's disease
    Mager, PP
    Reinhardt, R
    Fischer, K
    MOLECULAR SIMULATION, 2001, 26 (06) : 367 - +
  • [7] Mechanism of interaction of Alzheimer's disease drugs with aggregates of β- amyloid peptide (Aβ 1-42)
    Ramakrishnan, Latha
    Bhattarai, Nirjal
    Henning, Phillip P.
    Rajbhandari, Labchan
    Thapa, Rajan B.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237 : 421 - 421
  • [8] Alzheimer's amyloid β peptide (1-42) fibrils are not always neurotoxic
    Varadarajan, S
    Yatin, S
    Butterfield, DA
    ALZHEIMERS REPORTS, 2000, 3 (02): : 71 - 76
  • [9] In vitro fibrillization of Alzheimer's amyloid-β peptide (1-42)
    Tiiman, Ann
    Krishtal, Jekaterina
    Palumaa, Peep
    Tougu, Vello
    AIP ADVANCES, 2015, 5 (09):
  • [10] In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid β-peptide (1-42)
    Butterfield, DA
    Yatin, SM
    Link, CD
    OXIDATIVE/ENERGY METABOLISM IN NEURODEGENERATIVE DISORDERS, 1999, 893 : 265 - 268